Method and apparatus for the non-invasive measurement of tissue function and metabolism by determination of steady-state fluorescence anisotropy
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G01N-021/00
A61B-005/00
A61B-005/1455
G01N-021/64
A61B-005/145
출원번호
US-0015659
(2018-06-22)
등록번호
US-10194804
(2019-02-05)
발명자
/ 주소
Zuckerman, Ralph
출원인 / 주소
CELLVIEW IMAGING INC.
대리인 / 주소
Knobbe, Martens, Olson & Bear, LLP
인용정보
피인용 횟수 :
0인용 특허 :
20
초록▼
A non-invasive measurement of biological tissue reveals information about the function of that tissue. Polarized light is directed onto the tissue, stimulating the emission of fluorescence, due to one or more endogenous fluorophors in the tissue. Fluorescence anisotropy is then calculated. Such meas
A non-invasive measurement of biological tissue reveals information about the function of that tissue. Polarized light is directed onto the tissue, stimulating the emission of fluorescence, due to one or more endogenous fluorophors in the tissue. Fluorescence anisotropy is then calculated. Such measurements of fluorescence anisotropy are then used to assess the functional status of the tissue, and to identify the existence and severity of disease states. Such assessment can be made by comparing a fluorescence anisotropy profile with a known profile of a control.
대표청구항▼
1. An apparatus for non-invasively evaluating tissue comprising: a stimulator configured to apply a stimulation to a tissue in a resting state in order to cause the tissue to transition to a stimulated state;an illuminator configured to irradiate the tissue in the resting and stimulated states with
1. An apparatus for non-invasively evaluating tissue comprising: a stimulator configured to apply a stimulation to a tissue in a resting state in order to cause the tissue to transition to a stimulated state;an illuminator configured to irradiate the tissue in the resting and stimulated states with light in order to cause at least one endogenous fluorophor in the tissue to fluoresce;a detector configured to detect fluorescence emitted by the at least one fluorophor in the tissue in the resting and stimulated states; anda processor configured to: determine a resting steady-state fluorescence anisotropy of the fluorescence emitted by the at least fluorophor in the tissue in the resting state;determine a stimulated steady-state fluorescence anisotropy of the fluorescence emitted by the at least fluorophor in the tissue in the stimulated state;construct a resting fluorescence anisotropy map of a region of the tissue based on the resting steady-state fluorescence anisotropy;construct a stimulated fluorescence anisotropy map of the region of the tissue based on the stimulated steady-state fluorescence anisotropy;subtract the resting fluorescence anisotropy map from the stimulated fluorescence anisotropy map; andidentify a tissue dysfunction based on a result of the subtraction. 2. The apparatus of claim 1, wherein metabolism of the tissue in the stimulated state is increased when compared to metabolism of the tissue in the resting state. 3. The apparatus of claim 1, wherein the result of the subtraction is indicative of a tissue metabolism level, and wherein the processor is configured to identify the tissue dysfunction based on a comparison of the result of the subtraction with a threshold associated with a metabolism level in non-diseased tissue. 4. The apparatus of claim 3, wherein the processor is configured to identify the tissue dysfunction in response to a determination that the result of the subtraction is below the threshold. 5. The apparatus of claim 1, wherein the processor is configured to subtract the resting fluorescence anisotropy map from the stimulated fluorescence anisotropy map point by point or pixel by pixel. 6. The apparatus of claim 1, wherein the illuminator is configured to irradiate the tissue with polarized light. 7. The apparatus of claim 6, wherein the detector comprises a polarizer configured to separate the light emitted by the tissue into polarized components parallel and perpendicular to a plane of the polarized light. 8. The apparatus of claim 1, wherein the at least one fluorophor comprises lipoamide dehydrogenase (LipDH). 9. The apparatus of claim 1, wherein the processor is configured to: determine the resting steady-state fluorescence anisotropy within a latency period of a metabolic response of the tissue to the stimulation; anddetermine the stimulated steady-state fluorescence anisotropy outside of the latency period of the metabolic response of the tissue to the stimulation. 10. The apparatus of claim 1, wherein the stimulation comprises at least one of light or supplemental oxygen. 11. The apparatus of claim 1, wherein the tissue dysfunction comprises at least one of presence or severity of a disease, and wherein the disease comprises at least one of cancer, optic neuropathy, neurodegenerative disease, or mitochondrial disease. 12. The apparatus of claim 1, wherein the tissue comprises at least one of skin tissue, cervix tissue, abdominal tissue, esophagus tissue, stomach tissue, gut tissue, lung tissue, or ocular tissue. 13. The apparatus of claim 1, wherein: the tissue comprises at least one another endogenous fluorophor different from the at least one fluorophor;the illuminator is further configured to cause the at least one another fluorophor to fluoresce; andthe at least one of the detector or processor is further configured to filter fluorescence emitted by the at least one fluorophor and at least one another fluorophor to isolate the fluorescence emitted by the at least one fluorophor. 14. A method for non-invasively evaluating tissue comprising: causing a tissue to transition from a resting state to a stimulated state by applying stimulation to the tissue;irradiating the tissue in the resting and stimulated states with light in order to cause a first endogenous fluorophor in the tissue to fluoresce;detecting fluorescence emitted by the first fluorophor in the tissue in the resting and stimulated states; andby a processor: determining a resting steady-state fluorescence anisotropy of the fluorescence emitted by the first fluorophor in the tissue in the resting state;determining a stimulated steady-state fluorescence anisotropy of the fluorescence emitted by the first fluorophor in the tissue in the stimulated state;constructing a resting fluorescence anisotropy map of a region of the tissue based on the resting steady-state fluorescence anisotropy;constructing a stimulated fluorescence anisotropy map of the region of the tissue based on the stimulated steady-state fluorescence anisotropy; andidentifying a tissue dysfunction based on subtracting the resting fluorescence anisotropy map from the stimulated fluorescence anisotropy map. 15. The method of claim 14, wherein: a result of the subtraction is indicative of a tissue metabolism level; andthe method further comprises, by the processor: identifying the tissue dysfunction based on determining that the result of the subtraction is below a threshold associated with a metabolism level in non-diseased tissue. 16. The method of claim 14, further comprising, by the processor, subtracting the resting fluorescence anisotropy map from the stimulated fluorescence anisotropy map point by point or pixel by pixel. 17. The method of claim 14, wherein: the irradiating comprises irradiating the tissue with polarized light; andthe detecting comprises separating the light emitted by the tissue into polarized components parallel and perpendicular to a plane of the polarized light. 18. The method of claim 14, wherein the first fluorophor comprises lipoamide dehydrogenase (LipDH). 19. The method of claim 14, wherein the tissue comprises a second endogenous fluorophor different from the first fluorophor, the irradiating further comprises causing the second fluorophor to fluoresce, and the method further comprises: isolating the fluorescence emitted by the first fluorophor by filtering fluorescence emitted by the first and second fluorophors. 20. The method of claim 14, further comprising, by the processor: determining the resting steady-state fluorescence anisotropy within a latency period of a metabolic response of the tissue to the stimulation; anddetermining the stimulated steady-state fluorescence anisotropy outside of the latency period of the metabolic response of the tissue to the stimulation. 21. The method of claim 14, wherein the stimulation comprises at least one of light or supplemental oxygen. 22. The method of claim 14, wherein the tissue dysfunction comprises at least one of presence or severity of a disease, and wherein the disease comprises at least one of cancer, optic neuropathy, neurodegenerative disease, or mitochondrial disease.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (20)
Pinsky Bertram G. (Hayward CA) Hoffman Robert A. (Livermore CA), Apparatus and method for phase resolved fluorescence lifetimes of independent and varying amplitude pulses.
Vari Sandor G. (Van Nuys CA) Papazoglou Theodore (Athens CA GBX) Grundfest Warren S. (Los Angeles CA), Apparatus and method of use for a photosensitizer enhanced fluorescence based biopsy needle.
James Douglas R. (London CAX) Ware William R. (London CAX), Luminescence system and method for determining the nature of substances by measuring fluorescence and phosphorescence pr.
Zuckerman Ralph (Philadelphia PA), Method and apparatus for the in vivo measurement of oxygen concentration levels by the indirect determination of fluoesc.
Zuckerman Ralph (226 W. Rittenhouse Square Philadelphia PA 19103), Method and apparatus for the measurement of analyte concentration levels by the steady-state determination of fluorescen.
Zuckerman Ralph (226 W. Rittenhouse Sq. Philadelphia PA 19103), Method for the measurement of oxygen concentration levels by the steady-state determination of fluorescence lifetime.
Buchert Janusz (265 Cabrini Blvd. ; #6E New York NY 10040), Method, apparatus and procedure for non-invasive monitoring blood glucose by measuring the polarization ratio of blood l.
Gourley Ted H. (Santa Ana CA) Maxwell Thomas P. (Santa Ana CA) Hacker Thomas G. (Anaheim CA) Miller William W. (Santa Ana CA) Yafuso Masao (El Toro CA), Sensor and method for sensing the concentration of a component in a medium.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.